menopausal estrogen therapy

Emerging evidence suggests menopausal estrogen-only therapy post-hysterectomy may reduce breast cancer risk both in general and BRCA mutation populations. Shared decision-making is key when considering therapy and surgical options for benign gynecologic conditions.